387 related articles for article (PubMed ID: 14557464)
1. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.
Lee JH; Chan JL; Yiannakouris N; Kontogianni M; Estrada E; Seip R; Orlova C; Mantzoros CS
J Clin Endocrinol Metab; 2003 Oct; 88(10):4848-56. PubMed ID: 14557464
[TBL] [Abstract][Full Text] [Related]
2. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies.
Gavrila A; Chan JL; Yiannakouris N; Kontogianni M; Miller LC; Orlova C; Mantzoros CS
J Clin Endocrinol Metab; 2003 Oct; 88(10):4823-31. PubMed ID: 14557461
[TBL] [Abstract][Full Text] [Related]
3. [Reduced resistin levels in patients with type 2 diabetes mellitus].
Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
[TBL] [Abstract][Full Text] [Related]
4. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.
Silha JV; Krsek M; Skrha JV; Sucharda P; Nyomba BL; Murphy LJ
Eur J Endocrinol; 2003 Oct; 149(4):331-5. PubMed ID: 14514348
[TBL] [Abstract][Full Text] [Related]
5. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
[TBL] [Abstract][Full Text] [Related]
6. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.
Chen CC; Li TC; Li CI; Liu CS; Wang HJ; Lin CC
Metabolism; 2005 Apr; 54(4):471-5. PubMed ID: 15798953
[TBL] [Abstract][Full Text] [Related]
7. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
[TBL] [Abstract][Full Text] [Related]
8. Correlation between serum resistin level and adiposity in obese individuals.
Azuma K; Katsukawa F; Oguchi S; Murata M; Yamazaki H; Shimada A; Saruta T
Obes Res; 2003 Aug; 11(8):997-1001. PubMed ID: 12917505
[TBL] [Abstract][Full Text] [Related]
9. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G
J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036
[TBL] [Abstract][Full Text] [Related]
10. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
Al-Harithy RN; Al-Ghamdi S
Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119
[TBL] [Abstract][Full Text] [Related]
11. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.
Vozarova de Courten B; Degawa-Yamauchi M; Considine RV; Tataranni PA
Diabetes; 2004 May; 53(5):1279-84. PubMed ID: 15111497
[TBL] [Abstract][Full Text] [Related]
12. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
[TBL] [Abstract][Full Text] [Related]
13. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.
McTernan PG; Fisher FM; Valsamakis G; Chetty R; Harte A; McTernan CL; Clark PM; Smith SA; Barnett AH; Kumar S
J Clin Endocrinol Metab; 2003 Dec; 88(12):6098-106. PubMed ID: 14671216
[TBL] [Abstract][Full Text] [Related]
14. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.
Yannakoulia M; Yiannakouris N; Blüher S; Matalas AL; Klimis-Zacas D; Mantzoros CS
J Clin Endocrinol Metab; 2003 Apr; 88(4):1730-6. PubMed ID: 12679465
[TBL] [Abstract][Full Text] [Related]
15. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia.
Lee JH; Bullen JW; Stoyneva VL; Mantzoros CS
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E625-32. PubMed ID: 15522996
[TBL] [Abstract][Full Text] [Related]
16. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
[TBL] [Abstract][Full Text] [Related]
17. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance.
Pagano C; Marin O; Calcagno A; Schiappelli P; Pilon C; Milan G; Bertelli M; Fanin E; Andrighetto G; Federspil G; Vettor R
J Clin Endocrinol Metab; 2005 Jul; 90(7):4335-40. PubMed ID: 15870134
[TBL] [Abstract][Full Text] [Related]
18. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration.
Gavrila A; Chan JL; Miller LC; Heist K; Yiannakouris N; Mantzoros CS
J Clin Endocrinol Metab; 2005 Feb; 90(2):1047-54. PubMed ID: 15546902
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
Pfützner A; Langenfeld M; Kunt T; Löbig M; Forst T
Clin Lab; 2003; 49(11-12):571-6. PubMed ID: 14651328
[TBL] [Abstract][Full Text] [Related]
20. Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome.
Barb D; Wadhwa SG; Kratzsch J; Gavrila A; Chan JL; Williams CJ; Karchmer AW; Mantzoros CS
J Clin Endocrinol Metab; 2005 Sep; 90(9):5324-8. PubMed ID: 15956078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
